A detailed history of Quadrature Capital LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 2,323 shares of MEDP stock, worth $774,697. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,323
Previous 30,381 92.35%
Holding current value
$774,697
Previous $12.3 Billion 92.2%
% of portfolio
0.02%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $10.4 Million - $11.9 Million
-28,058 Reduced 92.35%
2,323 $957 Million
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $8.65 Million - $12.6 Million
30,381 New
30,381 $12.3 Billion
Q4 2023

Feb 13, 2024

SELL
$227.52 - $312.68 $4.7 Million - $6.46 Million
-20,669 Reduced 59.72%
13,941 $4.27 Million
Q3 2023

Nov 14, 2023

BUY
$233.98 - $281.67 $6.94 Million - $8.36 Million
29,669 Added 600.47%
34,610 $8.38 Million
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $5.09 Million - $6.53 Million
-27,195 Reduced 84.62%
4,941 $1.19 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $5.11 Million - $7.02 Million
-29,328 Reduced 47.72%
32,136 $6.04 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $9.41 Million - $13.9 Million
61,464 New
61,464 $13.1 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $515,207 - $795,090
-3,710 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $677,965 - $845,509
3,710 New
3,710 $806,000
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $772,222 - $1.05 Million
-7,060 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$92.95 - $130.61 $25,468 - $35,787
-274 Reduced 3.74%
7,060 $788,000
Q2 2018

Aug 10, 2018

SELL
$34.03 - $45.46 $166,440 - $222,344
-4,891 Reduced 40.01%
7,334 $0
Q4 2017

Feb 12, 2018

BUY
$32.46 - $38.31 $396,823 - $468,339
12,225
12,225 $0

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.